Live webcasts of these events will be available on the Investors & Media section of Mersana’s website at www.mersana.com. Archived replays will be available for approximately 90 days following the ...

A live webcast of the presentation will be available at Events and Presentations. A replay of the webcast will be archived and available following the event.

A team led by Mount Sinai researchers has identified stem cell populations and mechanisms underlying age-related degeneration ...

Zongertinib, an investigational treatment for HER2-mutant advanced NSCLC, has received FDA priority review, showing positive ...

The risk for cardiovascular mortality in survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis peaks within ...

Discover recent findings that indicate that c-Rel expression is upregulated in psoriatic skin lesions and decreases following ...

The Food and Drug Administration (FDA) has granted Priority Review to the New Drug Application for zongertinib for the treatment of adult patients with ...

Bristol Myers' Opdivo improved overall survival in resectable NSCLC, per final Phase 3 data. The study confirms its benefit when combined with chemotherapy.

First identified by Stevens and Johnson in 1922, SJS and TEN are now recognized as disorders with a continuum of severity, ...

The table below is a review of notable updates that occurred in January 2025 for investigational products in development.